News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,440 Results
Type
Article (5484)
Company Profile (18)
Press Release (227938)
Section
Business (84324)
Career Advice (463)
Deals (15481)
Drug Delivery (10)
Drug Development (20092)
Employer Resources (30)
FDA (3794)
Job Trends (4020)
News (123903)
Policy (7947)
Tag
Academia (327)
Accelerated approval (2)
Adcomms (3)
Allergies (10)
Alliances (15800)
ALS (22)
Alzheimer's disease (253)
Antibody-drug conjugate (ADC) (24)
Approvals (3829)
Artificial intelligence (48)
Autoimmune disease (5)
Automation (4)
Bankruptcy (98)
Best Places to Work (2962)
BIOSECURE Act (1)
Biosimilars (14)
Biotechnology (22)
Bladder cancer (12)
Brain cancer (7)
Breast cancer (53)
Cancer (562)
Cardiovascular disease (30)
Career advice (395)
Career pathing (3)
CAR-T (40)
Cell therapy (120)
Cervical cancer (3)
Clinical research (16969)
Collaboration (224)
Compensation (186)
Complete response letters (2)
COVID-19 (344)
CRISPR (9)
C-suite (116)
Cystic fibrosis (16)
Data (623)
Depression (7)
Diabetes (50)
Diagnostics (2114)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (17)
Drug pricing (8)
Drug shortages (1)
Duchenne muscular dystrophy (15)
Earnings (41650)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (39015)
Executive appointments (332)
FDA (4169)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (207)
Gene editing (26)
Generative AI (2)
Gene therapy (62)
GLP-1 (132)
Government (456)
Guidances (90)
Healthcare (5271)
Huntington's disease (1)
IgA nephropathy (7)
Immunology and inflammation (17)
Indications (6)
Infectious disease (362)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (4)
Intellectual property (17)
Interviews (53)
IPO (8015)
IRA (3)
Job creations (1146)
Job search strategy (362)
Kidney cancer (7)
Labor market (5)
Layoffs (104)
Leadership (5)
Legal (2375)
Liver cancer (20)
Lung cancer (86)
Lymphoma (47)
Management (10)
Manufacturing (60)
MASH (30)
Medical device (3979)
Medtech (3980)
Mergers & acquisitions (7700)
Metabolic disorders (145)
Multiple sclerosis (10)
NASH (6)
Neurodegenerative disease (13)
Neuropsychiatric disorders (1)
Neuroscience (366)
NextGen: Class of 2025 (1722)
Non-profit (738)
Now hiring (3)
Obesity (65)
Opinion (31)
Ovarian cancer (19)
Pain (17)
Pancreatic cancer (15)
Parkinson's disease (30)
Partnered (4)
Patents (25)
Patient recruitment (35)
Peanut (5)
People (25040)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase I (5160)
Phase II (7325)
Phase III (5871)
Pipeline (743)
Policy (11)
Postmarket research (628)
Preclinical (1961)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (107)
Rare diseases (77)
Real estate (2109)
Recruiting (8)
Regulatory (5564)
Reports (15)
Research institute (328)
Resumes & cover letters (68)
Rett syndrome (5)
Schizophrenia (24)
Series A (35)
Series B (25)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1087)
Stomach cancer (2)
Supply chain (10)
Tariffs (7)
Vaccines (48)
Venture capitalists (4)
Weight loss (29)
Women's health (1)
Date
Today (75)
Last 7 days (366)
Last 30 days (1141)
Last 365 days (10267)
2025 (4028)
2024 (11587)
2023 (13958)
2022 (19495)
2021 (20510)
2020 (18900)
2019 (13709)
2018 (10548)
2017 (10339)
2016 (9432)
2015 (12422)
2014 (9822)
2013 (7939)
2012 (8587)
2011 (9052)
2010 (8796)
Location
Africa (190)
Alabama (14)
Alaska (2)
Arizona (61)
Arkansas (1)
Asia (16079)
Australia (1669)
California (2209)
Canada (753)
China (297)
Colorado (87)
Connecticut (101)
Delaware (34)
Europe (25472)
Florida (317)
Georgia (36)
Idaho (23)
Illinois (121)
India (8)
Indiana (68)
Iowa (2)
Japan (81)
Kansas (24)
Kentucky (11)
Louisiana (5)
Maine (42)
Maryland (251)
Massachusetts (1773)
Michigan (88)
Minnesota (148)
Mississippi (1)
Missouri (24)
Montana (16)
Nebraska (12)
Nevada (26)
New Hampshire (16)
New Jersey (656)
New Mexico (5)
New York (553)
North Carolina (358)
North Dakota (3)
Northern California (1075)
Ohio (64)
Oklahoma (5)
Oregon (4)
Pennsylvania (400)
Puerto Rico (1)
Rhode Island (13)
South America (283)
South Carolina (9)
Southern California (800)
Tennessee (50)
Texas (259)
United States (7976)
Utah (66)
Virginia (49)
Washington D.C. (11)
Washington State (187)
West Virginia (2)
Wisconsin (26)
233,440 Results for "generon shanghai corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS)
December 3, 2024
·
4 min read
Press Releases
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
December 23, 2024
·
7 min read
GenSci Launches Global Innovation Hub in Shanghai
Changchun GeneScience Pharmaceutical, a subsidiary of Changchun High-Tech Industries, held a groundbreaking ceremony for its new global headquarters and research & development center at Shanghai Zhangjiang International Medical Park on December 15th.
December 23, 2023
·
7 min read
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis
Shanghai Argo Biopharmaceutical Co., Ltd. announced that it has entered into two exclusive license and collaboration agreements with Novartis PHARMA AG.
January 7, 2024
·
3 min read
MDimune Inc. broadens its global footprint with residency at JLABS @ Shanghai
MDimune Inc. announced today that it took up residence at Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’), located in Shanghai, China, starting in September.
October 5, 2023
·
1 min read
Policy
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform
Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.
May 2, 2024
·
4 min read
Business
Novartis’s Dealmaking Spree Continues with Calypso Buyout, Shanghai Argo RNAi Collab
A day after inking an AI deal with Alphabet’s Isomorphic Labs, Novartis is back at it, acquiring Calypso Biotech and tying up with Shanghai Argo in two RNA-i-focused pacts.
January 8, 2024
·
2 min read
·
Tristan Manalac
Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
Shanghai Junshi Biosciences Co., Ltd, announced its financial results for the full year of 2023 and provided corporate updates.
March 28, 2024
·
8 min read
1 of 23,344
Next
